Chemical Computing Group MOE

Molecular Operating Environment (MOE) is a comprehensive drug discovery platform developed by Chemical Computing Group. It integrates visualisation, modelling, and simulation tools into a single package, facilitating the design and analysis of small molecules, peptides, and biologics.

Key features include:

• Structure-Based Design: Enables precise modelling of protein-ligand interactions to optimise therapeutic candidates.
• Fragment-Based Design: Assists in identifying and assembling molecular fragments to create novel compounds.
• Pharmacophore Discovery: Facilitates the identification of essential molecular features responsible for biological activity.
• Biologics Applications: Supports protein and antibody modelling, crucial for developing biopharmaceuticals.
• Cheminformatics and QSAR: Provides tools for quantitative structure-activity relationship analysis and chemical informatics.

MOE is widely utilised in pharmaceutical and biotechnology industries, as well as in academic research institutions. Its applications span various scientific domains, including medicinal chemistry, structural biology, bioinformatics, and molecular modelling.

First released in 1994, MOE has continually evolved to meet the advancing needs of the scientific community, maintaining its relevance and prominence in drug discovery and molecular design.